Your browser doesn't support javascript.
loading
The genomic epidemiology of SARS-CoV-2 variants of concern in Kenya
George Githinji; Arnold W. Lambisia; Ifeanyi Omah; Aine W. O'Toole; Khadija Said Mohamed; Mike Mwanga; Maureen W. Mburu; Timothy O. Makori; John Mwita Morobe; Edidah M. Ong'era; Leonard Ndwiga; Zaydah R. de Laurent; Kimita Gathii; Kelvin Thiongo; DonWilliams O. Omuoyo; Edith Chepkorir; Jennifer Musyoki; Leonard Kingwara; Damaris Matoke; Samuel O. Oyola; Clayton Onyango; John Waitumbi; Wallace Bulimo; Samoel Khamadi; John N. O. Kiiru; Samson Kinyanjui; Matthew Cotten; Benjamin Tsofa; Isabella L. Ochola-Oyier; Andrew Rambaut; D. James Nokes; Philip Bejon; Charles N Agoti.
Affiliation
  • George Githinji; KEMRI-Wellcome Trust Research Programme
  • Arnold W. Lambisia; KEMRI-Wellcome Trust Research Programme
  • Ifeanyi Omah; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK
  • Aine W. O'Toole; Institute of Evolutionary Biology, University of Edinburgh
  • Khadija Said Mohamed; KEMRI-Wellcome Trust Research Programme
  • Mike Mwanga; KEMRI-Wellcome Trust Research Programme
  • Maureen W. Mburu; KEMRI-Wellcome Trust Research Programme
  • Timothy O. Makori; KEMRI-Wellcome Trust Research Programme
  • John Mwita Morobe; KEMRI-Wellcome Trust Research Programme
  • Edidah M. Ong'era; KEMRI-Wellcome Trust Research Programme
  • Leonard Ndwiga; KEMRI-Wellcome Trust Research Programme
  • Zaydah R. de Laurent; KEMRI-Wellcome Trust Research Programme
  • Kimita Gathii; Kenya Medical Research Institute, Basic Science Laboratory
  • Kelvin Thiongo; Center for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi, Kenya
  • DonWilliams O. Omuoyo; KEMRI-Wellcome Trust Research Programme
  • Edith Chepkorir; Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
  • Jennifer Musyoki; KEMRI-Wellcome Trust Research Programme
  • Leonard Kingwara; National Public Health Laboratory, Ministry of Health, Nairobi, Kenya
  • Damaris Matoke; Center for Biotechnology Research and Development, Kenya Medical Research Institute, Nairobi, Kenya
  • Samuel O. Oyola; International Livestock Research Institute, Nairobi, Kenya
  • Clayton Onyango; Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya
  • John Waitumbi; Kenya Medical Research Institute Basic Science Laboratory
  • Wallace Bulimo; Kenya Medical Research Institute, Nairobi, Kenya
  • Samoel Khamadi; Center for Virus Research, Kenya Medical Research Institute, Nairobi, Kenya
  • John N. O. Kiiru; National Public Health Laboratory, Ministry of Health, Nairobi, Kenya
  • Samson Kinyanjui; KEMRI-Wellcome Trust Research Programme
  • Matthew Cotten; MRC/UVRI & LSHTM Uganda Research Unit, Entebbe, Uganda
  • Benjamin Tsofa; KEMRI-Wellcome Trust Research Programme
  • Isabella L. Ochola-Oyier; KEMRI-Wellcome Trust Research Programme
  • Andrew Rambaut; University of Edinburgh
  • D. James Nokes; Kemri-Wellcome Trust Research Programme
  • Philip Bejon; KEMRI-Wellcome Trust Research Programme
  • Charles N Agoti; KEMRI-Wellcome Trust Research Programme
Preprint in English | medRxiv | ID: ppmedrxiv-22281446
ABSTRACT
The emergence and establishment of SARS-CoV-2 variants of concern presented a major global public health crisis across the world. There were six waves of SARS-CoV-2 cases in Kenya that corresponded with the introduction and eventual dominance of the major SARS-COV-2 variants of concern, excepting the first 2 waves that were both wild-type virus. We estimate that more than 1000 SARS-CoV-2 introductions occurred in the two-year epidemic period (March 2020 - September 2022) and a total of 930 introductions were associated with variants of concern namely Beta (n=78), Alpha(n=108), Delta(n=239) and Omicron (n=505). A total of 29 introductions were associated with A.23.1 variant that circulated in high frequencies in Uganda and Rwanda. The actual number of introductions is likely to be higher than these conservative estimates due to limited genomic sequencing. Our data suggested that cryptic transmission was usually underway prior to the first real-time identification of a new variant, and that multiple introductions were responsible. Following emergence of each VOC and subsequent introduction, transmission patterns were associated with hotspots of transmission in Coast, Nairobi and Western Kenya and follows established land and air transport corridors. Understanding the introduction and dispersal of major circulating variants and identifying the sources of new introductions is important to inform public health control strategies within Kenya and the larger East-African region. Border control and case finding reactive to new variants is unlikely to be a successful control strategy.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study Language: English Year: 2022 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Observational study Language: English Year: 2022 Document type: Preprint
...